Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Coding Corner Questions: Rheumatology Word Search

  |  Issue: December 2019  |  

Questions

  1. What type of drug is interchangeable with an FDA-approved biologic?
  2. What drug is used in conjunction with infliximab, unless the patient cannot tolerate it?
  3. What can be used as a key element in an evaluation and management (E/M) service, along with the history, exam and medical decision making?
  4. What drives the level of an E/M visit?
  5. What is the name of the radiologic procedure included in CPT code 20611 arthrocentesis, aspiration and/or injection of a large joint?
  6. What does the acronym ICD stand for?
  7. What does the acronym CPT stand for?
  8. What part of the body would be injected if using CPT code 20552?
  9. What is the name of a disease that is often age-related?
  10. What is the name of the disease referring to degeneration of joint cartilage and underlying bone causing pain and stiffness, especially to the knees, hips and fingers?
Coding Corner Questions: Rheumatology Word Search

(click for larger image)

Click here for the answer(s).

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles
    Biosimilars Debate Heats up over Cost Savings, Safety Concerns

    Biosimilars Debate Heats up over Cost Savings, Safety Concerns

    After years of speculation about potential cost savings and debates on safety, biosimilars are about to step onto the stage of rheumatic disease treatment. On Feb. 9, the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) met in Washington, D.C., and recommended the approval of CT-P13, a proposed biosimilar to infliximab (Remicade),…